CCL18 and breast cancer: GM-CSF was highly expressed in about 29% of human breast cancer samples, and the infiltration of CCL18-positive macrophages was often observed at the invasive front of tumors, where cancer cells displayed more mesenchymal features and expressed high levels of GM-CSF.